Kirsty Tunna

Papers

Total Citations

H-Index

About

Dr. Kirsty Tunna is a leading urological surgeon and researcher whose work sits at the critical intersection of focal therapy and robotic surgery for prostate cancer. Her primary research focuses on optimizing treatment pathways for men with recurrent or residual disease after initial focal therapy, a rapidly evolving field aimed at reducing overtreatment. Dr. Tunna’s most significant contribution is her leadership in the landmark RAFT (Robotic surgery After Focal Therapy) trial, a prospective single-group interventional study that rigorously assessed the toxicity and outcomes of salvage robotic surgery. The 2021 paper detailing these results, which has garnered 20 citations, provides essential safety and efficacy data for clinicians managing this complex patient cohort. By systematically evaluating the feasibility and morbidity of robotic salvage procedures, her work directly informs clinical decision-making and helps define best practices for men facing treatment failure. Dr. Tunna’s research is pivotal in bridging the gap between innovative focal treatments and established surgical salvage, offering a clearer, evidence-based roadmap for personalized prostate cancer care.